Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hiscox ( (GB:HSX) ) has provided an update.
Hiscox Ltd has announced a change in the voting rights held by Boston Partners, formerly known as Robeco Investment Management, Inc., which is based in New York, USA. As of June 2, 2025, Boston Partners’ voting rights in Hiscox have decreased from 5.298% to 4.93%, marking a disposal of voting rights. This change may impact Hiscox’s shareholder dynamics and influence within the company, although the broader implications for stakeholders are not detailed in the release.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Spark’s Take on GB:HSX Stock
According to Spark, TipRanks’ AI Analyst, GB:HSX is a Outperform.
Hiscox’s strong earnings call and positive technical analysis are the most significant factors contributing to its score. While financial performance shows some areas of concern, such as cash flow, the overall position is solid, backed by strategic initiatives and shareholder returns.
To see Spark’s full report on GB:HSX stock, click here.
More about Hiscox
Hiscox Ltd is a non-UK insurance company that specializes in providing a range of insurance products and services. The company is known for its focus on niche markets, offering tailored insurance solutions for businesses and high-net-worth individuals.
Average Trading Volume: 1,255,127
Technical Sentiment Signal: Strong Buy
Current Market Cap: £4.3B
See more data about HSX stock on TipRanks’ Stock Analysis page.

